Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/208726
Title: | miRNA nanoencapsulation to regulate the programming of the blood-brain barrier permeability by hipoxia. |
Author: | Figueroa Becerra, Esteban Caballero Roman, Aitor Ticó Grau, Josep R. Miñarro Carmona, Montserrat Nardi Ricart, Anna González Candia, Alejandro |
Keywords: | Micro RNAs Anoxèmia MicroRNAs Anoxemia |
Issue Date: | 11-Sep-2022 |
Publisher: | Elsevier B.V. |
Abstract: | Central nervous system (CNS)-related diseases are difficult to treat as most therapeutic agents they cannot reach the brain tissue, mainly due to the blood-brain barrier (BBB), arguably the tightest barrier between the human body and cerebral parenchyma, which routinely excludes most xenobiotic therapeutics compounds. The BBB is a multicellular complex that structurally forms the neurovascular unit (NVU) and is organized by neuro-endothelial and glial cells. BBB breakdown and dysfunction from the cerebrovascular cells lead to leakages of systemic components from the blood into the CNS, contributing to neurological deficits. Understanding the molecular mechanisms that regulate BBB permeability and disruption is essential for establishing future therapeutic strategies to restore permeability and improve cerebrovascular health. MicroRNAs (miRNAs), a type of small noncoding RNAs, are emerging as an important regulator of BBB integrity by modulating gene expression by targeting mRNA transcripts. miRNAs is implicated in the development and progression of various illnesses. Conversely, nanoparticle carriers offer unprecedented opportunities for cell-specific controlled delivery of miRNAs for therapeutic purposes. In this sense, we present in this graphical review critical evidence in the regulation of cell junction expression mediated by miRNAs induced by hypoxia and for the use of nanoparticles for the delivery of miRNA-based therapeutics in the treatment of BBB permeability. |
Note: | Reproducció del document publicat a: |
It is part of: | Current Research in Pharmacology and Drug Discovery ( CRPHAR, 2022, p. 1-5 |
URI: | http://hdl.handle.net/2445/208726 |
ISSN: | 2590-2571 |
Appears in Collections: | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
251957.pdf | 1.39 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License